New President and CEO

CHICAGO, Jun 01, 2015- Clinical Innovations, a member of The Pritzker Group‘s family of companies and a leading global provider of medical devices with special emphasis on labor and delivery,oday announced the appointment of Ken Reali as its president and chief executive officer.

Reali joins Clinical Innovations following a distinguished career in the healthcare industry including 24 years in the medical device sector. During his tenure, he held various leadership positions at global medical device companies including Biomet, Stryker and Smith & Nephew. Most recently, Reali served as president and CEO of Baxano Surgical, Inc. , a publicly traded medical device company, where he led the development and launch of multiple new products as well as the acquisition of new technologies.

“Ken has demonstrated exemplary leadership for over two decades across the evolving medical device industry with a proven track record of innovation and strategic market expansion,” said Mike Lynch, Pritzker Group Private Capital’s healthcare operating partner.

“His collaborative leadership and experience spanning sales and marketing, new product development and business development will be an excellent fit for the culture and growth strategy at Clinical Innovations,” said Tony Pritzker, managing partner of Pritzker Group.

About Clinical Innovations

Clinical Innovations is the largest healthcare manufacturer exclusively focused on labor and delivery. Already a market leader in several categories with products such as the Koala® Intrauterine Pressure Catheter and Kiwi® Vacuum-Assisted Delivery System, Clinical Innovations is expanding its global presence while directly researching and developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and their babies throughout the world. Clinical Innovations is a Pritzker Group company. For more information, visit

About The Pritzker Group’s Middle-Market Investment Team

Pritzker Group, led by Tony and J.B. Pritzker, has three principal investment teams: Private Capital, which acquires and operates leading North America-based companies; Venture Capital, which provides early-stage and growth venture funding to technology companies throughout the United States; and Asset Management, which partners with top-performing investment managers across global public markets.

Pritzker Group Private Capital acquires North America-based middle-market companies with leading positions in the manufactured products, services and healthcare sectors. The firm’s permanent, proprietary capital base allows for efficient decision making, broad flexibility with transaction structure and investment horizon, and alignment with management teams focused on creating long-term value. Pritzker Group brings significant resources, expertise and credibility in building businesses and is an ideal partner for entrepreneur- and family-owned companies. For more information, visit